Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Clin Cancer Res. 2022 Jun 1;28(11):2329–2338. doi: 10.1158/1078-0432.CCR-21-3849

Table 1.

Patient characteristics

Variables Cohort A
N=45 (%)#
Cohort B
N=43 (%)
p-
value
Age * Median 64.0 (57.0 – 68.0) 61.0 (56.5 – 68.5) 0.70
Gender Male 37 (82) 28 (65) 0.11
Female 8 (18) 15 (35)
Race White 40 (89) 37 (86) 0.89
Black 3 (7) 3 (7)
Other 2 (4) 3 (7)
ECOG 0 9 (20) 19 (44) 0.03
1 33 (73) 20 (47)
2 3 (7) 4 (9)
Smoking History Yes 33 (73) 27 (63) 0.41
No 12 (27) 16 (37)
Primary Site Oral Cavity 10 (22) 17 (40) 0.53
Oropharynx (OP) 24 (53) 17 (40)
Larynx 6 (13) 6 (14)
Hypopharynx 3 (7) 2 (5)
Unknown Primary (UP) 2 (4) 1 (2)
p16 IHC OP+UP pos 22 (49) 14 (33) 0.14
OP neg 4 (9) 4 (9)
Non-OP pos 0 (0) 4 (9)
Non-OP neg 19 (42) 21 (49)
PD-L1 CPS <1 7 (16) 7 (16) 0.84
1-19 13 (29) 13 (30)
≥20 19 (42) 20 (47)
NA 6 (13) 3 (7)
Line of prior therapy for R/M HNSCC 0 11 (24) 43 (100) N/A
1 27 (60) 0
2 5 (11) 0
3 2 (4) 0
*

Median and inter-quartile range is given for age

#

Reference (21)

N/A – not applicable

R/M HNSCC – recurrent and/or metastatic head and neck squamous cell carcinoma